FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards

Nov.06.2024
FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
The new Fumot Tornado 4-in-1 e-cigarette from FUMOT is now available on UK sites like Vapesourcing and Powervapeshop. The product complies with EU TPD standards and offers approximately 4,000 puffs.

Recently, 2Firsts noted that FUMOT's new 4-in-1 product, the Fumot Tornado 4in1, has been listed on the brand's official website as well as on UK e-cigarette distributor sites like Vapesourcing and Powervapeshop. The product complies with TPD standards and offers approximately 4,000 puffs.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Fumot Tornado 4in1 | Image source: vapesourcing

 

Specifically, the features of the Fumot Tornado 4in1 include:

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Mapping: 2Firsts

 

At the InterTabac tobacco exhibition held in September, the FUMOT brand was interviewed by the 2Firsts team. Brand representatives said, "New large disposable products that meet TPD standards are emerging," and emphasized the importance of actively complying with regulatory standards for long-term stability. The brand also launched several innovative products, such as "2+10," at the exhibition to meet the demands of the German market.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
FUMOT brand products are listed on the vapesourcing website|Image source: vapesourcing

 

According to observations by 2Firsts, websites that offer online sales of FUMOT e-cigarettes in the UK are relatively limited. FUMOT products were not found on popular sites such as VapeUK, VapeClub, eCigaretteDirect, and ZeroVapes. However, on sites like Vapesourcing and PowerVapeShop, where FUMOT products are available, the offerings mainly consist of high-puff disposable e-cigarettes.

 

In a review article on the Fumot Tornado 4in1 by the e-cigarette website *Planet of the Vapes*, it was noted: “They [referring to the FUMOT brand] have many devices that do not comply with TPD (Tobacco Products Directive) regulations, but also a few that do, which is why their business is global.”

 

“Some of the flavors [of the Fumot Tornado 4in1] are indeed well-blended.”

 

“Since they are 4-in-1, you might find a flavor in the pack you purchase that you don’t enjoy.”

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Review article of the Fumot Tornado 4in1 released by planetofthevapes|Image source planetofthevapes

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Review article of Fumot Tornado 4in1 published by Planet of the Vapes | Image source: Planet of the Vapes

 

It is worth noting that on FUMOT’s official website, a separate “TPD Series” section is listed under the product category, featuring products compliant with TPD standards. This series includes low-puff disposables, open systems, refillable models, and 4-in-1 multi-flavor devices.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
FUMOT official website TPD Series | Image source: FUMOT official website

 

2Firsts will continue to monitor the latest e-cigarette products and market trends globally, providing the public with accurate and authoritative industry information.

 


 

2Firsts' product column remains committed to delivering readers the latest product updates in the new tobacco field. We invite readers to submit insights and news on e-cigarette developments.

 

For unique perspectives or information, feel free to contact us at carrie.cai@2firsts.com or scan the QR code below.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
Germany collected €9.789 billion in total tobacco tax revenue from January through August 2026, down 10.8% from a year earlier, according to the Federal Ministry of Finance. Germany's tobacco tax base covers not only cigarettes and fine-cut tobacco but also heated tobacco and vaping liquids taxed as tobacco substitutes. The German Association of the Tobacco Industry and Novel Products, or BVTE, citing federal statistical data, said tax-paid cigarette volume fell 12.6% to 40.6 billion sticks. BVTE is using the latest figures to argue against further tax increases planned from 2027 through 2030, while Germany's parliament is scheduled to hold a first reading of the bill on September 24.
Sep.23
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22